difficulty walking (gait ataxia)
Results: GHK-Cu alleviated weight loss, improved the disease activity index (DAI), reduced colonic edema and shortening, attenuated inflammatory damage, increased goblet cell numbers, suppressed inflammatory cytokines such as TNF-, IL-6, and IL-1, and promoted mucosal repair
As a doctor, theres a lot of burden on your shoulders when you are prescribing something with insufficient evidence, but the patients insist on giving it a try. With no formal approvals surrounding their use from regulatory bodies like the Drugs Controller General of India (DCGI), they are considered off-label treatments
For Canadians dealing with metabolic syndrome, prediabetes, or elevated cardiovascular risk markers, the possibility of targeted visceral fat reduction adds a health dimension beyond cosmetic weight loss